Artelo Biosciences, Inc.
ARTL
$7.16
-$0.15-2.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -74.34% | -64.59% | -63.12% | -90.20% | -77.58% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -56.62% | -17.05% | -70.49% | -63.39% | -60.47% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -72.82% | -63.36% | -63.80% | -83.12% | -76.71% |
|
|
|||||
| Total Current Assets | -72.82% | -63.36% | -63.80% | -83.12% | -76.71% |
| Net Property, Plant & Equipment | -35.35% | -32.41% | -29.31% | -26.61% | 371.43% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 10,833.33% | 0.00% | 0.00% | 0.00% |
| Total Assets | -40.38% | -40.20% | -47.67% | -66.05% | -63.98% |
|
|
|||||
| Total Accounts Payable | 81.09% | 516.91% | 460.95% | 313.34% | 35.38% |
| Total Accrued Expenses | 488.52% | 116.67% | 0.00% | -72.29% | 103.33% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.29% | 14.71% | 9.09% | 16.13% | 52.17% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 128.22% | 597.27% | 507.66% | 288.90% | 37.26% |
|
|
|||||
| Total Current Liabilities | 128.22% | 597.27% | 507.66% | 288.90% | 37.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -57.97% | -48.72% | -41.38% | -38.54% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 121.24% | 532.26% | 461.15% | 250.43% | 42.60% |
|
|
|||||
| Common Stock & APIC | 16.58% | 10.50% | 3.58% | 1.63% | 1.78% |
| Retained Earnings | -25.69% | -26.94% | -23.22% | -22.70% | -24.38% |
| Treasury Stock & Other | -34.65% | -27.06% | -45.32% | -11.82% | 0.49% |
| Total Common Equity | -144.52% | -109.95% | -119.26% | -93.16% | -75.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -144.52% | -109.95% | -119.26% | -93.16% | -75.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -144.52% | -109.95% | -119.26% | -93.16% | -75.69% |
|
|
|||||